Infarct angioplasty: Beyond stents and glycoprotein IIb/IIIa inhibitors

Heart

Volumn 91, Issue SUPPL. 3, 2005, Pages

  Dixon, Simon R ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALDARET; CARDIAC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; GLUCOSE; GRANULOCYTE COLONY STIMULATING FACTOR; INSULIN; MCC 135; PEXELIZUMAB; POTASSIUM; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANGIOPLASTY; ARTIFICIAL EMBOLISM; CLINICAL TRIAL; DEVICE; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; RHEOLYTIC THROMBECTOMY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT; STENT; SYMPTOMATOLOGY;

ANGIOPLASTY; CALCIUM; COMPLEMENT INACTIVATOR PROTEINS; DRUG COMBINATIONS; DRUG IMPLANTS; GLUCOSE; HUMANS; HYPOTHERMIA, INDUCED; INSULIN; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; POTASSIUM; STENTS; THROMBECTOMY;

EID: 20044366089     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.060251     Document Type: Review

References (41)

1. Braunwald E. Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival: should the paradigm be expanded? Circulation 1989;79:441-4.
2. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1496-508.
3. Forman MB, Virmani R, Puett DW. Mechanisms and therapy of myocardial reperfusion injury. Circulation 1990;81(suppl IV):IV-69-78.
4. Kloner RA. Does reperfusion injury exist in humans? J Am Coll Cardiol 1993;21:637-45.
5. Ambrosia G, Tritto I. Reperfusion injury: experimental evidence and clinical implications. Am Heart J 1999;138:569-75.
6. Erbel R, Heusch G. Coronary microembolization. J Am Coll Cardiol 2000;36:22-4.
7. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992;85:1699-705.
8. van't Hof AWJ, Liem A, de Boer MJ, et al. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Lancet 1997;350:615-19.
9. Wu KC, Zerhouni EA, Judd RM, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-72.
10. Roe MT, Ohman EM, Maas AC, et al. Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion. J Am Coll Cardiol 2001;37:9-18.
11. Chien GL, Wolff RA, Davis RF, et al. "Normothermic range" temperature affects myocardial infarct size. Cardiovasc Res 1994;28:1014-17.
12. Duncker DJ, Klassen CL, Ishibashi Y, et al. Effect of temperature on myocardial infarction in swine. Am J Physiol 1996;270:H1189-99.
13. Hale SL, Dave RH, Kloner RA. Regional hypothermia reduces myocardial necrosis even when instituted after the onset of ischemia. Basic Res Cardiol 1997;92:351-7.
14. Miki T, Liu GS, Cohen MV, et al. Mild hypothermia reduces infarct size in the beating rabbit heart: a practical intervention for acute myocardial infarction. Basic Res Cardiol 1998;93:372-83.
15. Dae MW, Gao DW, Sessler DI, et al. Effect of endovascular cooling on myocardial temperature, infarct size, and cardiac output in human-sized pigs. Am J Physiol Heart Circ Physiol 2002;282:H1584-91.
16. Dixon SR, Whitbourn RJ, Dae MW, et al. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol 2002;40:1928-34.
17. Kandzari DE, Chu A, Brodie BR, et al. Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study). Am J Cardiol 2004;93:636-9.
18. O'Neill WW, on behalf of the COOL-MI Investigators. Cooling as an adjunct to primary PCI for myocardial infarction. Presented at Transcatheter Cardiovascular Therapeutics 2003, Washington DC, USA, September, 2003.
19. Grines CL, on behalf of the ICE-IT Investigators. Intravascular cooling adjunctive to percutaneous coronary intervention for acute myocardial infarction. Presented at Transcatheter Cardiovascular Therapeutics 2004, Washington DC, USA, September, 2004.
20. Spears JR, Wang B, Wu X, et al. Aqueous Oxygen. A highly O2-supersaturated infusate for regional correction of hypoxemia and production of hyperoxemia. Circulation 1997;96:4385-91.
21. Dixon SR, Bartorelli AL, Marcovitz PA, et al. Initial experience with hyperoxemic reperfusion after primary angioplasty far acute myocardial infarction. Results of a pilot study utilizing intracoronary Aqueous Oxygen therapy. J Am Coll Cardiol 2002;39:387-92.
22. Spears JR, Henney C, Prcevski P, et al. Aqueous oxygen hyperbaric reperfusion in a porcine model of myocardial infarction. J Invas Cardiol 2002;14:160-6.
23. Bartorelli AL. Hyperoxemic perfusion for treatment of reperfusion microvascular ischemia in patients with myocardial infarction. Am J Cardiovasc Drugs 2003;3:253-63.
24. O'Neill WW, on behalf of the AMIHOT Investigators. Acute myocardial infarction with hyperoxemic therapy: a prospective, randomized, multicenter trial. Presented at the Annual Scientific Session of the American College of Cardiology, New Orleans, LA, March, 2004;(AMIHOT).
25. Granger CB, Mahaffey KW, Weaver D, et al. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction. Circulation 2003;108:1184-90.
26. van der Horst IC, Zijlstra F, van't Hof AWJ, et al. Glucose-insulin- potassium infusion in patients treated with primary angioplasty far acute myocardial infarction. J Am Coll Cardiol 2003;42:784-91.
27. Mehta S, Diaz R, on behalf of the CREATE-ECLA Investigators. Clinical trial of metabolic modulation in acute myocardial infarction treatment evaluation-Estudios Cardiologicos Latinoamérica. Presented at the Annual Scientific Session of the American Heart Association, New Orleans, LA, November, 2004.
28. Tzivoni D. Reduction of infarct size and improved left ventricular function with IV Caldaret (MCC-135) in patients with ST elevation myocardial infarction undergoing primary PCI. Presented at the Annual Scientific Session of the American College of Cardiology, New Orleans, LA, March, 2004.
29. Napodano M, Pasquetto G, Sacca S, et al. Intracoronary thrombectomy improves myocardial reperfusion in patients undergoing direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 2003;42:1395-402.
30. Lefevre T, Ludwig J, on behalf of the XAMINE ST Investigators. X-Sizer in AMI patients for negligible embolization and optimal ST resolution. Presented at Transcatheter Cardiovascular Therapeutics 2003, Washington DC, USA, September, 2003.
31. Ali A, on behalf of the AIMI Investigators. AngioJet Rheolytic thrombectomy in patients undergoing primary angioplasty for acute myocardial infarction. Presented at Transcatheter Cardiovascular Therapeutics 2004, Washington DC, USA, September, 2004.
32. Stone GW, Webb J, Cox DA, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation. A randomized controlled trial. JAMA 2005;293:1063-72.
33. Limbruno U, Micheli A, de Carlo M, et al. Mechanical prevention of distal embolization during primary angioplasty. Safety, feasibility and impact on myocardial reperfusion. Circulation 2003;108:171-6.
34. Saia F, Lemos PA, Lee CH, et al. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction. A clinical and angiographic study. Circulation 2003;108:1927-9.
35. Lemos PA, Saia F, Hofma SH, et al. Short and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol 2004;43:704-8.
36. Assmus B, Schachinger V, Teupe C, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Circulation 2002;106:3009-17.
37. Strauer BE, Brehm M, Aeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002;106:1913-18.
38. Kang HJ, Kim HS, Zhang SY, et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilized with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trial. Lancet 2004;363:751-6.
39. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomized controlled clinical trial. Lancet 2004;364:141-8.
40. Siminiak T. Percutaneous transvenous transplantation of autologous myoblasts in the treatment of postinfarction heart failure: the POZNAN trial. Presented at the Annual Scientific Session of the American College of Cardiology, New Orleans, LA, March, 2004.
41. Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction. Final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 2004;44:1690-9.